St. Jude using adult cancer drugs to double-team childhood brain tumors

Children with an aggressive form of the most common childhood brain tumor, medulloblastoma, face a tough prognosis. Effective treatments are limited, and long-term survival is poor. But today there is new hope thanks to a discovery from St. Jude Children’s Research Hospital involving a pair of drugs already being used to treat adults with cancer.

Tags:

2014
news
medulloblastoma
brain

To wipe childhood cancer off the map, scientists must chart its genomic landscape

Childhood Liver Cancer "Signatures" May Help Predict Response to Chemo

New chemical technology leads to better targeted therapeutics against high-risk leukemia in the lab

Hopes of a new curative treatment for children with neuroblastoma

Scientists are a step closer to finding a low toxicity treatment for childhood leukaemia

Researchers identify an Achilles’ heel in neuroblastoma

To save children with cancer, doctors turn to new weapons

Childhood Cancer Survivors Are at an Increased Risk for Hospitalization Years After Treatment Ends

Novel targeted therapy could be effective treatment option for deadly childhood cancer

Gene That Causes Deadliest Brain Tumor Also Causes Childhood Cancer

Recent Posts

St. Jude using adult cancer drugs to double-team childhood brain tumors

Archive

Search By Tags